EA201391030A1 - Композиции моноциклина для местного применения и способы их применения - Google Patents
Композиции моноциклина для местного применения и способы их примененияInfo
- Publication number
- EA201391030A1 EA201391030A1 EA201391030A EA201391030A EA201391030A1 EA 201391030 A1 EA201391030 A1 EA 201391030A1 EA 201391030 A EA201391030 A EA 201391030A EA 201391030 A EA201391030 A EA 201391030A EA 201391030 A1 EA201391030 A1 EA 201391030A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- application
- compositions
- methods
- monocycline
- local
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Обеспечены композиции миноциклина для местного применения со сниженной флуоресценцией. В некоторых случаях композиции включают количества активного средства миноциклин, связанного с пористыми частицами кальция. Также обеспечены способы применения композиций, например при лечении акне.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161434368P | 2011-01-19 | 2011-01-19 | |
PCT/US2012/021926 WO2012100097A2 (en) | 2011-01-19 | 2012-01-19 | Topical minocycline compositions and methods of using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201391030A1 true EA201391030A1 (ru) | 2014-07-30 |
EA031630B1 EA031630B1 (ru) | 2019-01-31 |
Family
ID=46516388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201391030A EA031630B1 (ru) | 2011-01-19 | 2012-01-19 | Композиции миноциклина для местного применения и способы их применения |
Country Status (13)
Country | Link |
---|---|
US (3) | US9539266B2 (ru) |
EP (1) | EP2665483B1 (ru) |
JP (1) | JP2014502999A (ru) |
KR (1) | KR102044236B1 (ru) |
CN (2) | CN108619519A (ru) |
AU (1) | AU2012207203B2 (ru) |
BR (1) | BR112013018352A2 (ru) |
CA (1) | CA2861357C (ru) |
EA (1) | EA031630B1 (ru) |
IL (1) | IL227538B (ru) |
MX (1) | MX354137B (ru) |
SG (2) | SG10201600332TA (ru) |
WO (1) | WO2012100097A2 (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
ES2532906T5 (es) | 2002-10-25 | 2022-03-23 | Foamix Pharmaceuticals Ltd | Espuma cosmética y farmacéutica |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
EP3065717A1 (en) | 2013-11-04 | 2016-09-14 | Biopharmx, Inc. | Dosage form comprising an active ingredient and a plurality of solid porous microcarriers |
IN2013MU03646A (ru) * | 2013-11-20 | 2015-07-31 | Lupin Ltd | |
CA2977612A1 (en) | 2015-02-25 | 2016-09-01 | Sun Pharma Advanced Research Company Ltd | Nanoparticulate composition |
US9918998B2 (en) | 2015-03-23 | 2018-03-20 | BioPharmX, Inc. | Pharmaceutical tetracycline composition for dermatological use |
US20160287615A1 (en) * | 2015-04-03 | 2016-10-06 | BioPharmX, Inc. | Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application |
CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US20210308154A1 (en) | 2020-03-24 | 2021-10-07 | Hovione Scientia Limited | Methods and Compositions for Treating Meibomian Gland Dysfunction |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4701320A (en) * | 1984-11-29 | 1987-10-20 | Lederle (Japan), Ltd. | Composition stably containing minocycline for treating periodontal diseases |
DE3613213A1 (de) * | 1986-04-18 | 1987-10-22 | Merck Patent Gmbh | Tricalciumphosphat fuer implantationsmaterialien |
US4948575A (en) | 1989-01-24 | 1990-08-14 | Minnesota Mining And Manufacturing Company | Alginate hydrogel foam wound dressing |
JPH0832551B2 (ja) | 1989-06-24 | 1996-03-29 | 旭光学工業株式会社 | 多孔質リン酸カルシウム系化合物粒子及びその製造方法 |
US5292495A (en) | 1991-05-27 | 1994-03-08 | Kowa-Chemical Industry Co., Ltd. | Porous particles of calcium carbonate and method for the preparation thereof |
US5604200A (en) | 1994-05-02 | 1997-02-18 | Taylor-Mccord; Darlene | Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing |
US5674539A (en) | 1994-12-09 | 1997-10-07 | Tomas; Robert E. | Method of treating skin and composition |
US8333996B2 (en) | 1995-05-19 | 2012-12-18 | Etex Corporation | Calcium phosphate delivery vehicle and adjuvant |
US6096324A (en) | 1995-06-13 | 2000-08-01 | Laboratory Skin Care | Methods of delivering materials into the skin, and compositions used therein |
US5607980A (en) * | 1995-07-24 | 1997-03-04 | The Procter & Gamble Company | Topical compositions having improved skin feel |
US6395311B2 (en) | 1998-04-29 | 2002-05-28 | Univera Pharmaceuticals, Inc. | Multicomponent biological vehicle |
US6262020B1 (en) | 2000-02-15 | 2001-07-17 | Alphamed Pharmaceuticals Corp. | Topical wound therapeutic compositions |
US6573249B2 (en) | 2000-02-15 | 2003-06-03 | Alphamed Pharmaceutical Corp. | Topical wound therapeutic compositions |
CN1106861C (zh) | 2000-05-19 | 2003-04-30 | 清华大学 | 纳米相钙磷盐/胶原/聚乳酸骨复合多孔材料的制备方法 |
JP4161031B2 (ja) | 2000-10-31 | 2008-10-08 | 独立行政法人産業技術総合研究所 | 亜鉛含有リン酸カルシウム微粒子含有懸濁液または粒子溶媒混合系及び亜鉛欠乏症治療剤 |
US20030018587A1 (en) | 2001-07-20 | 2003-01-23 | Althoff Oliver T. | Checkout system for on-line, card present equivalent interchanges |
US7005136B2 (en) * | 2002-03-29 | 2006-02-28 | Ethicon, Inc. | Bone replacement materials utilizing bioabsorbable liquid polymers |
JP2004075662A (ja) | 2002-06-20 | 2004-03-11 | Mukku:Kk | 徐放性組成物、その製造方法およびその製剤 |
WO2004076352A1 (ja) | 2003-02-27 | 2004-09-10 | Okutama Kogyo Co., Ltd. | 球状炭酸カルシウム及びその製造方法 |
US20040180091A1 (en) | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
WO2004091577A1 (en) | 2003-04-17 | 2004-10-28 | Porten Pharmaceutical Ab | Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions |
DE10323175A1 (de) | 2003-05-22 | 2004-12-23 | TÜV Industrie Service GmbH - TÜV Rheinland Group | Prüfhebel |
US7348060B2 (en) | 2003-08-22 | 2008-03-25 | National Insititute For Materials Science | Porous and spherical calcium phosphate particle comprising metal ion, and porous multilayer calcium phophate particle |
WO2005084637A2 (en) | 2004-02-13 | 2005-09-15 | Nod Pharmaceuticals, Inc. | Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof |
SE527610C2 (sv) | 2004-06-15 | 2006-04-25 | Promimic Ab | Förfarande för framställning av syntetiskt, kristallint kalciumfosfat i nanostorlek |
US20060025735A1 (en) | 2004-07-30 | 2006-02-02 | Berg Charles J Jr | Absorbent article with color matched surfaces |
RU2357758C2 (ru) | 2004-10-07 | 2009-06-10 | Кабусики Кайся Санги | Препараты для чрескожной и чресслизистой доставки |
CA2586035A1 (en) | 2004-11-01 | 2006-05-11 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use |
US20060257358A1 (en) * | 2005-05-13 | 2006-11-16 | Depuy Products, Inc. | Suspension of calcium phosphate particulates for local delivery of therapeutic agents |
US8147860B2 (en) * | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
JP4766606B2 (ja) | 2006-03-30 | 2011-09-07 | パウダーテック株式会社 | 電子写真現像剤用フェライトキャリア及びその製造方法、並びに電子写真現像剤 |
US20080051335A1 (en) | 2006-05-02 | 2008-02-28 | Kleiner Lothar W | Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers |
US20080063681A1 (en) * | 2006-09-11 | 2008-03-13 | Ebi, L.P. | Therapeutic bone replacement material |
EP2068952A2 (en) | 2006-10-05 | 2009-06-17 | CAM Aesthetics B.V. i.o. | Hydroxyapatite tissue filler and its preparation and use |
EP2086598B1 (en) | 2006-11-03 | 2015-05-27 | BioMimetic Therapeutics, LLC | Compositions and methods for arthrodetic procedures |
JP2008291010A (ja) | 2007-04-26 | 2008-12-04 | Galenisearch Laboratories Inc | 局所滞留性徐放性マイクロ粒子 |
US20090214601A1 (en) * | 2007-09-28 | 2009-08-27 | Chappa Ralph A | Porous Drug Delivery Devices and Related Methods |
BR112012006635B8 (pt) * | 2008-09-23 | 2021-05-25 | Laboratory Skin Care Inc | composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas |
ES2942923T3 (es) * | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
CN102639159B (zh) | 2009-08-04 | 2015-04-01 | 皮斯洛克斯有限公司 | 离子取代的磷酸钙颗粒 |
-
2012
- 2012-01-19 AU AU2012207203A patent/AU2012207203B2/en not_active Ceased
- 2012-01-19 SG SG10201600332TA patent/SG10201600332TA/en unknown
- 2012-01-19 JP JP2013550590A patent/JP2014502999A/ja active Pending
- 2012-01-19 SG SG2013054945A patent/SG192028A1/en unknown
- 2012-01-19 CN CN201810454074.0A patent/CN108619519A/zh active Pending
- 2012-01-19 BR BR112013018352A patent/BR112013018352A2/pt not_active Application Discontinuation
- 2012-01-19 WO PCT/US2012/021926 patent/WO2012100097A2/en active Application Filing
- 2012-01-19 KR KR1020137021645A patent/KR102044236B1/ko active IP Right Grant
- 2012-01-19 EP EP12736073.3A patent/EP2665483B1/en active Active
- 2012-01-19 EA EA201391030A patent/EA031630B1/ru not_active IP Right Cessation
- 2012-01-19 MX MX2013008384A patent/MX354137B/es active IP Right Grant
- 2012-01-19 CA CA2861357A patent/CA2861357C/en active Active
- 2012-01-19 CN CN201280014391.1A patent/CN103781485A/zh active Pending
-
2013
- 2013-07-17 US US13/944,373 patent/US9539266B2/en active Active
- 2013-07-18 IL IL227538A patent/IL227538B/en active IP Right Grant
-
2016
- 2016-12-15 US US15/380,829 patent/US10080764B2/en active Active
-
2018
- 2018-08-21 US US16/107,541 patent/US10653707B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20140083921A (ko) | 2014-07-04 |
KR102044236B1 (ko) | 2019-11-13 |
WO2012100097A2 (en) | 2012-07-26 |
SG192028A1 (en) | 2013-08-30 |
AU2012207203A1 (en) | 2013-08-22 |
WO2012100097A3 (en) | 2012-10-26 |
EP2665483A4 (en) | 2015-11-11 |
CN108619519A (zh) | 2018-10-09 |
SG10201600332TA (en) | 2016-02-26 |
MX2013008384A (es) | 2014-07-30 |
US10080764B2 (en) | 2018-09-25 |
EP2665483A2 (en) | 2013-11-27 |
US9539266B2 (en) | 2017-01-10 |
CN103781485A (zh) | 2014-05-07 |
AU2012207203B2 (en) | 2017-08-03 |
CA2861357A1 (en) | 2012-07-26 |
EA031630B1 (ru) | 2019-01-31 |
IL227538A0 (en) | 2013-09-30 |
CA2861357C (en) | 2022-08-23 |
US20140186442A1 (en) | 2014-07-03 |
MX354137B (es) | 2018-02-14 |
US10653707B2 (en) | 2020-05-19 |
EP2665483B1 (en) | 2020-08-26 |
BR112013018352A2 (pt) | 2019-08-27 |
IL227538B (en) | 2018-07-31 |
US20170189427A1 (en) | 2017-07-06 |
US20190134067A1 (en) | 2019-05-09 |
JP2014502999A (ja) | 2014-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201391030A1 (ru) | Композиции моноциклина для местного применения и способы их применения | |
CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
EA201791850A1 (ru) | Борсодержащие малые молекулы | |
EA201400771A1 (ru) | Новые производные азетидина, фармацевтические композиции и их применение | |
EA201491330A1 (ru) | Терапевтически активные соединения и способы их использования | |
EA201492050A1 (ru) | Модуляторы ядерного транспорта и их применение | |
EA201400579A1 (ru) | Антитела к il-36r | |
EA201390682A1 (ru) | Спирооксиндольные антагонисты mdm2 | |
MX2019008122A (es) | Derivados de aminas heterociclicas que inhiben la transduccion de se?al mediada por cinasa asociada con el receptor de interleucina-1. | |
EA201390803A1 (ru) | Ингибиторы бромодомена и их применение | |
EA201591430A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
EA201391285A1 (ru) | Производные тетрагидрохинолина, полезные в качестве ингибиторов бромодомена | |
EA201401077A1 (ru) | Биспецифические антитела к человеческому tweak и человеческому il17 и их применения | |
EA201690044A1 (ru) | Модуляторы ядерного транспорта и их применение | |
EA201390804A1 (ru) | Лекарственная форма лакозамида для приема один раз в сутки | |
EA201492216A1 (ru) | Ингибиторы бромодомена и их применение | |
EA201590997A1 (ru) | Соединения и способы их применения | |
EA201590590A1 (ru) | Модуляторы рецептора андрогенов и их применение | |
EA201370018A1 (ru) | Составы рифаксимина и их применение | |
CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
EA201591427A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
WO2012106281A3 (en) | Multimodal trail molecules and uses in cellular therapies | |
EA201491617A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201591432A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
EA201270722A1 (ru) | Формы рифаксимина и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |